ÂÜÀòÂÒÂ×

Jeffrey Eiben is an experienced professional in the pharmaceutical industry, currently serving as the Regional Business Director for South Texas at Novo Nordisk. Previously, Jeffrey held multiple roles at Novo Nordisk, including Director of Commercial Execution for Obesity and Launch Readiness, as well as Director of Commercial Execution for the Central Area Diabetes Business Unit. Prior experience includes a position as Territory Manager at Kos Pharmaceuticals and as a Professional Representative at Merck. Jeffrey Eiben is pursuing a Bachelor of Science degree in Education with a Minor in Biology at Bowling Green State University, where academic involvement spans from 1998 to the present.